| Health Care Services |
When |
| Physical exam |
Annually |
| Clinical Screenings |
When |
Chlamydia screening and gonorrhea screening (STIs)
|
All sexually active women to be screened for STIs |
| HIV screening |
Annually for adolescents and adults at high risk |
Cervical cancer screening (females)
|
Start screening within three years of beginning sexual activity |
| Hearing screening |
Every three years
|
| Height, weight, BMI percentile and blood pressure |
During physical exam; nutrition and physical activity counseling for those
identified as high risk |
| Dyslipidemia screening (risk assessment based on family history and physical exam) |
Assessment annually. (Routine lab testing not recommended. May be done for children at high risk.) |
| Urinalysis |
Once between 11 and 21 years
|
Tuberculin skin test (PPD)
|
For those identified as high risk |
| Hemoglobin and hematocrit |
Once between 11 and 21 years; annually for menstruating teens |
| Depression screening |
During physical exam |
| Tobacco use |
During each visit |
| Alcohol/drug misuse |
During each visit |
| Prevention of dental cavities |
Prescribe oral fluoride supplementation to children through age 16 if primary water source is deficient. |
Safety, injury prevention
|
Anticipatory guidance at physician discretion
|
| Sexually transmitted infections |
Anticipatory guidance at physician discretion |
| Immunizations |
When |
Td/Tdap
Tetanus, diphtheria and acellular pertussis |
Every ten years.
(One dose of Tdap if pertussis booster was not received previously.) |
MMR
Measles, mumps and rubella |
Two doses if not vaccinated previously or no history of disease |
HepB
Hepatitis B |
May begin three-dose series if not previously vaccinated |
Var
Varicella (chickenpox) |
Two-dose series at least four weeks apart if no history of varicella and no previous vaccination |
Flu
Influenza |
Annually |
Pneumonia
Pneumococcal |
For high risk groups |
HepA
Hepatitis A |
Two doses for all adolescents up to age 18 |
| Meningococcal |
One dose if not vaccinated previously |
HPV
Human Papillomavirus |
Three-dose series for ages 13-18 on a zero, two and six-months schedule
if no previous vaccination. Minimum spacing: 4 weeks between #1 and
#2; 12 weeks between #2 and #3; must be 24 weeks between doses #1
and #3. |